All In Biotech

Drug Trial Radar · NCT03994471

Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.

A Study to EvaLuate the EffIcacy and Safety of XyloCore, a Glucose SparIng ExpeRimental Solution, for Peritoneal Dialysis

Last checked: Nov 20, 2026Latest source record: Mar 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 170 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

170

Planned (sponsor's estimate)

Start

Dec 14, 2022

Primary completion

Dec 31, 2026

Study completion Apr 28, 2027

Sponsor

Lead sponsor
Iperboreal Pharma SrlIndustry
Sponsor type
Industry
First posted
Jun 21, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Randomized, controlled, parallel groups, open-label, blinded end-point assessment, multicenter study, comparing the effects of a low glucose peritoneal dialysis solution, XyloCore, to glucose solutions (Physioneal, Fixioneal, Dianeal, Balance, Bicavera, Bicanova or Equibalance) only regimen, in patients with End-Stage Renal Disease (ESRD) receiving Continuous Ambulatory Peritoneal Dialysis (CAPD), over a 6-month study period.

Conditions

  • End Stage Renal Disease

Interventions

  • XyloCore Low Strenght, XyloCore Medium Strenght, XyloCore High StrenghtDrug

    XyloCore Low Strenght: 0.7% Xylitol, 0.5% Glucose, and 0.02% L-carnitine - or - XyloCore Medium Strenght: 1.5% Xylitol, 0.5% Glucose, and 0.02% L-carnitine - or - XyloCore High Strenght: 2.0% Xylitol, 1.5% Glucose, and 0.02% L-carnitine

  • 1.36%, 1.5%, 2.27%, 2.5%, 3.86%, 2.25% Glucose PD SolutionDrug

    Physioneal 35 or 40 (including Clear-Flex bag), Fixioneal 35 or 40, Dianeal or Dianeal Low Calcium have 1.36%, 2.27% or 3.86% glucose; Balance, Bicavera, Bicanova or Equibalance have 1.25%, 2.3%, 4.5% glucose.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Total weekly Kt/VureaTime frame: 24-week

Locations

41 sites in 6 countries. Site status is shown where the registry gives one.

  • Aalborg University

    Aalborg, Denmark · Not yet recruiting

  • Aarhus University Hospital

    Aarhus, Denmark · Recruiting

  • Zealand University Hospital

    Roskilde, Denmark · Recruiting

  • Dialysis Center DaVita

    Düsseldorf, Germany · Recruiting

  • Ospedale Madonna del Soccorso

    Ascoli Piceno, Italy · Recruiting

  • Ospedale Santa Maria Annunziata

    Bagno a Ripoli, Italy · Not yet recruiting

  • Azienda Universitaria Ospedaliera di Bari

    Bari, Italy · Recruiting

  • ASST Spedali Civili di Brescia

    Brescia, Italy · Not yet recruiting

  • Ospedale SS. Annunziata

    Chieti, Italy · Recruiting

  • IRCCS Policlinico San Martino

    Genova, Italy · Not yet recruiting

  • Ospedale Civile San Salvatore

    L’Aquila, Italy · Recruiting

  • ASST Fatebenefratelli-Sacco -Ospedale Luigi Sacco

    Milan, Italy · Recruiting

  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

    Milan, Italy · Not yet recruiting

  • Azienda Ospedaliera Universitaria di Modena

    Modena, Italy · Recruiting

  • AOU Università degli studi della Campania

    Naples, Italy · Recruiting

  • Università della Campania L.Vanvitelli

    Naples, Italy · Recruiting

  • Azienda Ospedaliera di Padova

    Padova, Italy · Not yet recruiting

  • Ospedale AUSL "Guglielmo da Saliceto"

    Piacenza, Italy · Recruiting

  • Ospedale S.Eugenio

    Roma, Italy · Not yet recruiting

  • Ospedale C. e G. Mazzoni

    San Benedetto del Tronto, Italy · Recruiting

  • Azienda Ospedaliera Terni

    Terni, Italy · Recruiting

  • Ospedale San Giovanni Bosco

    Torino, Italy · Recruiting

  • Azienda Ospedaliera Universitaria Integrata di Verona

    Verona, Italy · Recruiting

  • University Hospital A Coruña Fundación Profesor Novoa Santos

    A Coruña, Spain · Recruiting

  • Hospital U. Germans Trias i Pujol

    Badalona, Spain · Recruiting

  • Fundaciòn Puigvert

    Barcelona, Spain · Recruiting

  • Hospital Universitario Josep Trueta

    Girona, Spain · Recruiting

  • Fundacion Jimenez Diaz

    Madrid, Spain · Recruiting

  • Hospital Ramón y Cajal

    Madrid, Spain · Not yet recruiting

  • Hospital Universitario La Paz

    Madrid, Spain · Recruiting

  • Hospital Universitario Central De Asturias

    Oviedo, Spain · Recruiting

  • Halland County Hospital of Halmstad

    Halmstad, Sweden · Recruiting

  • Karolinska University Hospital

    Stockholm, Sweden · Recruiting

  • Heartlands Hospital

    Birmingham, United Kingdom · Recruiting

  • St Luke's Hospital

    Bradford, United Kingdom · Recruiting

  • University Hospitals Sussex

    Brighton, United Kingdom · Recruiting

  • Kent and Canterbury Hospital

    Canterbury, United Kingdom · Recruiting

  • Hammersmith Hospital

    London, United Kingdom · Recruiting

  • Churchill Hospital

    Oxford, United Kingdom · Recruiting

  • Sheffield Kidney Institute

    Sheffield, United Kingdom · Recruiting

Showing 40 of 41 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.